首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Atropine often results in complete atrioventricular block or sinus arrest after cardiac transplantation: an unpredictable and dose-independent phenomenon.
【24h】

Atropine often results in complete atrioventricular block or sinus arrest after cardiac transplantation: an unpredictable and dose-independent phenomenon.

机译:阿托品通常会导致心脏移植后完全的房室传导阻滞或窦性停搏:这是一种不可预测且与剂量无关的现象。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: A paradoxic response to atropine with development of atrioventricular (AV) block has been described in patients after heart transplantation (HTx). We investigated further the incidence and dose-response relationship of this paradoxic atropine response and explored predictive factors. METHODS: We investigated 25 clinically stable patients (age 55 +/- 2 years) 18 to 126 months after HTx. After endomyocardial biopsy, a temporary pacemaker was introduced and patients were monitored. Atropine was given in ascending doses (0.004 mg/kg body weight initially, total cumulative dose 0.035 mg/kg body weight). Physiologic tests were performed to evaluate the presence of reinnervation. RESULTS: In 20% of the patients (5/25), a paradoxic response to atropine was observed. Four patients exhibited third degree AV block, one of whom also demonstrated sinus arrest. A fifth patient showed sinus arrest only. In all patients but one, there was no ventricular escape rhythm before ventricular pacing was commenced(10 sec after block). The observed adverse effect was not correlated with the applied atropine dosage, and predisposing factors could not be identified, apart from a slightly lower resting heart rate (80 +/- 5 vs. 90 +/- 2 beats/min, P = 0.07). CONCLUSION: A significant proportion of patients respond paradoxically to atropine after HTx, leading to asystole as the result of sinus arrest or AV block. Although a plausible explanation for this effect remains speculative, our data indicate that the use of atropine or other anticholinergic drugs in patients after HTx is contraindicated.
机译:背景:在心脏移植(HTx)后的患者中已经描述了对阿托品的房室(AV)阻滞形成悖论。我们进一步研究了这种悖论性阿托品反应的发生率和剂量反应关系,并探讨了预测因素。方法:我们调查了HTx后18至126个月的25名临床稳定的患者(55 +/- 2岁)。进行心肌内膜活检后,引入了临时起搏器并对患者进行监测。阿托品以递增剂量给药(最初为0.004 mg / kg体重,总累积剂量为0.035 mg / kg体重)。进行生理测试以评估神经支配的存在。结果:在20%的患者中(5/25),观察到对阿托品的反常反应。四名患者表现出三度房室传导阻滞,其中一例也表现出窦性阻滞。第五名患者仅显示窦性逮捕。除一名患者外,所有患者在开始心律起搏前(封堵后10秒)均没有心律失常。观察到的不良反应与所用阿托品的剂量无关,除了静息心率略低(80 +/- 5 vs. 90 +/- 2次/ min,P = 0.07)外,无法确定诱发因素。 。结论:HTx后有相当大比例的患者对阿托品产生反常反应,由于窦停搏或房室传导阻滞导致心搏停止。尽管对此影响的合理解释仍是推测性的,但我们的数据表明在HTx术后患者中禁忌使用阿托品或其他抗胆碱能药物。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号